Pregnancy is the single most compelling reason to seek expert guidance before continuing or starting any nicotine product, including vaping. If you are pregnant and currently smoking, the urgency to switch is genuine — cigarette smoke causes documented harm to foetal development. If you are pregnant and considering using a vape shop product as a bridge to quitting, understanding both what the evidence supports and what it does not is essential before making that decision.
The Core Problem: Nicotine Is Not Safe in Pregnancy
The harm reduction framing that applies to adult smokers switching to vaping cannot be applied unchanged to pregnancy. The distinction matters because the primary target of concern shifts. For a non-pregnant adult smoker, the goal is to reduce exposure to combustion toxins — and vaping does that effectively. For a pregnant person, nicotine itself — regardless of the delivery method — is a significant concern for foetal development.
Nicotine crosses the placenta freely. Foetal blood nicotine concentrations can exceed maternal levels because the foetal liver lacks the metabolic enzymes to process nicotine efficiently. Nicotine acts on nicotinic acetylcholine receptors throughout the developing nervous system, and these receptors play important roles in neuronal migration, synapse formation and respiratory centre development during the first and second trimesters. Animal model studies have consistently shown that nicotine exposure during foetal neural development produces lasting alterations in brain architecture. Human epidemiological data, while complicated by confounding factors, is consistent with these findings.
Specific Risks Associated with Nicotine in Pregnancy
The evidence linking nicotine exposure during pregnancy to adverse outcomes is strongest for the following:
- Preterm birth: Nicotine-induced vasoconstriction reduces uteroplacental blood flow, increasing the risk of preterm labour. The risk is lower with vaping than with smoking but is not eliminated.
- Foetal growth restriction: Reduced placental blood flow impairs nutrient and oxygen delivery. Smaller birth weight is documented in both smoking and nicotine replacement therapy use in pregnancy, suggesting nicotine is a contributing factor independent of combustion products.
- Sudden Infant Death Syndrome (SIDS): Prenatal nicotine exposure alters the development of the brainstem respiratory control centres associated with SIDS. The mechanism is biological and plausible across all nicotine delivery methods.
- Neurodevelopmental effects: Studies have associated prenatal nicotine exposure with increased rates of attention deficit disorders, impulsivity and anxiety in childhood. These associations persist in studies that attempt to control for socioeconomic and genetic confounders.
Where Vaping Stands Compared to Smoking in Pregnancy
If the choice is between continuing to smoke and switching to vaping during pregnancy, the balance of evidence suggests that vaping is likely less harmful — primarily because it eliminates carbon monoxide exposure, which directly impairs foetal oxygen delivery, and removes the dozens of other combustion toxins that cross the placenta. The UKHSA and NHS have taken the cautious position that vaping is probably preferable to continued smoking in pregnancy, while emphasising that the evidence base is limited.
The key studies here are the SNAP (Smoking, Nicotine and Pregnancy) randomised controlled trial, published in the New England Journal of Medicine in 2020, which found that pregnant smokers randomised to e-cigarettes had higher rates of sustained smoking abstinence at 12 weeks than those on nicotine replacement therapy, without evidence of worse foetal outcomes at the gestational ages studied. This is genuinely useful data, but the study was not powered to detect differences in rare outcomes and did not follow children through postnatal development.
Clinical consensus: Complete cessation of nicotine in all forms is the safest choice during pregnancy. If a pregnant smoker cannot achieve complete cessation, switching to vaping is likely preferable to continued smoking — but this decision should be made with a healthcare provider, not independently. The goal remains complete cessation as soon as possible.
The Role of Aerosol Chemicals Beyond Nicotine
Nicotine is not the only concern in e-cigarette aerosol during pregnancy. Propylene glycol and vegetable glycerin at typical vaping exposures have not been identified as foetal teratogens in the available literature, but the evidence base for inhalation exposure specifically during pregnancy is thin. Flavour compounds, particularly those containing diacetyl or related diketones (common in some buttery/creamy e-liquid flavours) and high concentrations of aldehydes from overheated devices, represent additional exposures without established safety profiles in the context of foetal development.
This additional uncertainty strengthens the case for using only regulated, TPD-compliant products from established manufacturers during pregnancy if vaping is used at all — and for using the lowest nicotine strength that prevents a return to smoking, at a lower frequency than normal use would dictate.
Seeking Support: The Most Effective Path
The most effective approach for pregnant smokers is structured cessation support combined with whatever nicotine management tool a healthcare provider recommends. In Ireland, Stop Smoking Ireland provides a free, confidential service with advisors trained in supporting pregnant women through the specific challenges of quitting during pregnancy. The combination of behavioural support and nicotine management consistently outperforms either approach alone. If you are pregnant and smoking — or using any nicotine product — speaking to your midwife, GP or a Stop Smoking Ireland advisor before making any product choice is the right first step, not a product selection.